Mantle cell lymphoma - An entity comes of age

Blood

Volumn 87, Issue 11, 1996, Pages 4483-4494

  Weisenburger, Dennis D ^a   Armitage, James O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CELL DIFFERENTIATION; HISTOPATHOLOGY; HUMAN; LYMPHOCYTOMA; LYMPHOID CELL; MOLECULAR GENETICS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW;

EID: 0029943190     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.11.4483.bloodjournal87114483     Document Type: Review

References (119)

1. Berard CW, Dorfman RF: Histopathology of malignant lymphomas. Clin Haematol 3:39, 1974
2. Berard CW: Reticuloendothelial system: An overview of neoplasia, in Rebuck JW, Berard CW, Abell MR (eds): The Reticuloendothelial System. International Academy of Pathology Monograph No. 16. Baltimore, MD, Williams & Wilkins, 1975, p 301
3. Jaffe ES, Braylan RC, Namba K, Frank MM, Berard CW: Functional markers: A new perspective on malignant lymphomas. Cancer Treat Rep 61:1953, 1977
4. Namba K, Jaffe ES, Braylan RC, Soban EJ, Berard CW: Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas. Am J Clin Pathol 68:535, 1977
5. Lennert K, Stein H, Kaiserling E: Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer 31:29, 1975 (suppl II)
6. Lennert K: Malignant Lymphomas Other than Hodgkin's Disease. Berlin, Germany, Springer-Verlag, 1978, p 284
7. Tolksdorf G, Stein H, Lennert K: Morphological and immunological definition of a malignant lymphoma derived from germinal-center cells with cleaved nuclei (centrocytes). Br J Cancer 41:168 1980
8. Weisenburger DD, Kim H, Rappaport H: Mantle-zone lymphoma. A follicular variant of intermediate lymphocytic lymphoma. Cancer 49:1429, 1982
9. Palutke M, Eisenberg L, Mirchandani I, Tabaczka P, Husain M: Malignant lymphoma of small cleaved lymphocytes of the follicular mantle zone. Blood 59:317, 1982
10. Weisenburger DD, Nathwani BN, Diamond LW, Winberg CD, Rappaport H: Malignant lymphoma, intermediate lymphocytic type. A clinicopathologic study of 42 cases. Cancer 48:1415, 1981
11. Banks PM, Chan J, Cleary ML, Delsol G, de Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Mason D, Pileri S, Ralfkiaer E, Stein H, Warnke R: Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16:637, 1992
12. Zucca E, Stein H, Coffier B: European Lymphoma Task Force (ELTF): Report of the workshop on mantle cell lymphoma (MCL). Ann Oncol 5:507, 1994
13. Swerdlow SH, Habeshaw JA, Murray LJ, Dhaliwal HS, Lister TA, Stansfeld AG: Centrocytic lymphoma. A distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse. Am J Pathol 113:181, 1983
14. Weisenburger DD, Duggan MJ, Perry DA, Sanger WG, Armitage JO: Non-Hodgkin's lymphomas of mantle-zone origin, in Rosen PP, Fechner RE (eds): Pathology Annual. East Norwalk, CT, Appleton and Lange, 1991, p 139
15. Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES: Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 14:752, 1990
16. Lennert K, Feller AC: Histopathology of Non-Hodgkin's Lymphomas. Berlin, Germany, Springer-Verlag, 1992, p 93
17. Norton AJ, Mathews J, Pappa V, Shamash J, Love S, Rohatiner AZS, Lister TA: Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period. Ann Oncol 6:249, 1995
18. Pittaluga S, Wlodarska I, Stul MS, Thomas J, Verhoef G, Cassiman JJ, van den Berghe H, de Wolf-Peeters C: Mantle cell lymphoma: A clinicopathologic study of 55 cases. Histopathology 26:17, 1995
19. Segal GH, Masih AS, Fox AC, Jorgensen T, Scott M, Braylan RC: CDS-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood 85:1570, 1995
20. Duggan MJ, Weisenburger DD, Ye YL, Bast MA, Pierson JL, Linder J, Armitage JO: Mantle zone lymphoma. A clinicopathologic study of 22 cases. Cancer 66:522, 1990
21. Pombo de Oliveira MS, Jaffe ES, Catovsky D: Leukemic phase of mantle zone (intermediate) lymphoma: Its characterization in 11 cases. J Clin Pathol 42:962, 1989
22. Criel A, Billiet J, Vandenberghe E, van den Berghe H, Louwagie A, Hidajat M, Vanhoof A: Leukemic intermediate lymphocytic lymphomas: Analysis of twelve cases diagnosed by morphology. Leuk Lymphoma 8:381, 1992
23. O'Briain DS, Kennedy MJ, Daley PA, O'Brien AAJ, Tanner WA, Rogers P, Lawlor E: Multiple lymphomatous polyposis of the gastrointestinal tract. A clinicopathologically distinctive form of non-Hodgkin's lymphoma of B-cell centrocytic type. Am J Surg Pathol 13:691, 1989
24. Lavergne A, Brouland J, Launay E, Nemeth J, Ruskone-Fourmestraux A, Galian A: Multiple lymphomatous polyposis of the gastrointestinal tract. An extensive histopathologic and immunohistochemical study of 12 cases. Cancer 74:3042, 1994
25. Moynihan MJ, Bast MA, Chan WC, Delabie J, Wickert RS, Wu G, Weisenburger DD: Lymphomatous polyposis: a neoplasm of either follicular mantle or germinal center cell origin. Am J Surg Pathol (in press)
26. Zuckerberg LR, Medeiros JL, Ferry JA, Harris NL: Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 100:373, 1993
27. Molot RJ, Meeker TC, Wittwer CT, Perkins SL, Segal GH, Masih AS, Braylan RC, Kjeldsberg CR: Antigen expression and polymerase chain reaction amplification in mantle cell lymphomas. Blood 83:1626, 1994
28. Ott MM, Ott G, Kuse P, Porowski P, Gunzer U, Feller AC, Müller-Hermelink HK: The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology 24:329, 1994
29. Czader M, Porwit A, Tani E, Öst A, Mazur J, Auer G: DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki-67) in non-Hodgkin's lymphomas. Mod Pathol 8:51, 1995
30. Weisenburger DD, Sanger WG, Armitage JO, Purtilo DT: Intermediate lymphocytic lymphoma: Immunophenotypic and cytogenetic findings. Blood 69:1617, 1987
31. Rimokh R, Berger F, Cornillet P, Wahbi K, Rouault JP, Ffrench M, Bryon PA, Gadoux M, Gentilhomme O, Germain D, Magaud JP: Break in the bcl-1 locus is closely associated with intermediate lymphocytic lymphoma subtype. Genes Chrom Cancer 2:223, 1990
32. Leroux D, Le Marc'hadour F, Gressin R, Jacob MC, Keddari E, Monteil M, Caillot P, Jalbert P, Sotto JJ: Non-Hodgkin's lymphomas with t(11;14)(q13;q32): A subset of mantle zone/intermediate lymphocytic lymphomas? Br J Haematol 77:346, 1991
33. Vandenberghe E, de Wolfe-Peeters C, Wlodarska I, Stul M, Louwagie A, Verhoef G, Thomas J, Criel A, Cassiman JJ, Mecucci C, van den Berghe H: Chromosome 11q rearrangements in B non-Hodgkin's lymphoma. Br J Haematol 81:212, 1992
34. Komatsu H, Iida S, Yamamoto K, Mikuni C, Nitta M, Takahashi T, Ueda R, Seto M: A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the bcl-1 gene. Blood 84:1226, 1994
35. Neilson JR, Cai M, Bienz N, Leyland MJ: Leukemic mantle cell lymphoma with t(11;14) and trisomy 12 showing clinical features of stage AO B cell chronic lymphocytic leukemia. J Clin Pathol:Mol Pathol 48:M165, 1995
36. Daniel MT, Tagaud I, Flexor MA, Nogueira ME, Berger R, Jonveaux P: Leukemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11;14)(q13;q32): A subtype of mantle cell lymphoma? Br J Haematol 90:77, 1995
37. Chary-Reddy S, Prasad VS, Ahuja YR: Expression of common fragile sites in untreated non-Hodgkin's lymphoma with aphidicolin and folate deficiency. Cancer Lett 86:111, 1994
38. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A: Chromosome 11 translocation breakpoint at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 7:241, 1993
39. Rimokh R, Berger F, Delsol G, Chanin C, Berthéas MF, Ffrench M, Garoscio M, Felman P, Coiffier B, Bryon PA, Rochet M, Gentilhomme O, Germain D, Magaud JP: Rearrangement and overexpression of the bcl-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 81:3063, 1993
40. de Boer CJ, Loyson S, Kluin PM, Kluin-Nelemans HC, Schuuring E, van Krieken JHJM: Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: Rearrangements of the cyclin D1 gene. Cancer Res 53:4148, 1993
41. Hayashi T, Ohno H, Yamabe H, Nasu K, Miyaoka K, Fujii H, Akaogi T, Konishi H, Maseki N, Akasaka T, Kadowaki N, Fukuhara S, Okuma M: Clinical aspects of B-cell malignancy involving the BCL-1/PRAD1 locus. Int J Hematol 59:281, 1995
42. Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N, Tassies D, Jaffe ES, Montserrat E, Rozman C, Cardesa A: PRAD1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 84:2726, 1994
43. Williams ME, Swerdlow SH, Meeker TC: Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia 7:1437, 1993
44. Rimokh R, Berger F, Delsol G, Digonnet I, Rouault JP, Tigaud JD, Gadoux M, Coffier B, Bryon PA, Magaud JP: Detection of the chromosomal translocation in t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 83:1871, 1994
45. Luthra R, Hai S, Pugh WC: Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma. Diag Mol Pathol 4:4, 1995
46. Zucca E, Soldati G, Schlegelberger B, Booth MJ, Weber-Mathiesen K, Cavalli F, Cotter F: Detection of chromosome 11 alterations in blood and bone marrow by interphase cytogenetics in mantle cell lymphoma. Br J Haematol 89:665, 1995
47. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, Arnold A: PRAD 1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 88:9636, 1991
48. Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K, Meeker TC: Characterization of a candidate bcl-1 gene. Mol Cell Biol 11:4846, 1991
49. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A: A novel cyclin encoded by a bcl 1-linked candidate oncogene. Nature 350:512, 1991
50. Oka K, Ohno T, Kita K, Yamaguchi M, Takakura N, Nishii K, Miwa H, Shirakawa S: PRAD1 gene overexpression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma. Br J Haematol 86:786, 1994
51. de Boer CJ, van Krieken JHJM, Kluin-Nelemans HC, Kluin PM, Schuuring E: Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 10:1833, 1995
52. Rimokh R, Berger F, Bastard C, Klein B, French M, Archimbaud E, Rouault JP, Santa Lucia B, Duret L, Vuillaume M, Coiffier B, Bryon PA, Magaud JP: Rearrangement of CCND1 (BCL1/ PRAD1) 3′ untranslated region in mantle-cell lymphomas and the t(11q13)-associated leukemias. Blood 83:3689, 1994
53. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL: Cyclin D1 (bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145:86, 1994
54. Zuckerberg LR, Yang WI, Arnold A, Harris NL: Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am J Clin Pathol 103:756, 1995
55. Swerdlow SH, Yang WI, Zuckerberg LR, Harris NL, Arnold A, Williams ME: Expression of cyclin D1 protein in centrocytic/ mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Hum Pathol 26:999, 1995
56. Nakamura S, Seto M, Banno S, Suzuki S, Koshikawa T, Kitoh K, Kagami Y, Ogura M, Yatabe Y, Kojima M, Matoori T, Takahashi T, Ueda R, Suchi T: Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma. Jpn J Cancer Res 85:1270, 1994
57. Kuroda H, Komatsu H, Nakamura S, Niitsu Y, Takahashi T, Ueda R, Seto M: The positive nuclear staining observed with monoclonal antibody against PRAD1/cyclin D1 correlates with mRNA expression in mantle cell lymphoma. Jpn J Cancer Res 86:890, 1995
58. deBoer CJ, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM, van Krieken JHJM: Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 86:2715, 1995
59. Delmer A, Ajchenbaum-Cymbalista F, Tang R, Ramond S, Faussat AM, Marie JP, Zittoun R: Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13. Br J Haematol 89:798, 1995
60. Williams ME, Nichols GE, Swerdlow SH, Stoler MH: In situ hybridization detection of cyclin D1 mRNA centrocytic/mantle cell lymphoma. Ann Oncol 6:297, 1995
61. Hunter T, Pines J: Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79:573, 1994
62. Lukas J, Jadayel D, Bartikova J, Nacheva E, Dyer MJS, Strauss M, Bartek J: BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. Oncogene 9:2159, 1994
63. Daudy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA: Physical interactions of the retinoblastoma protein with human D cyclins. Cell 73:499, 1993
64. Louie DC, Offit K, Jaslow R, Parsa NZ, Murty VVVS, Schluger A, Chaganti RSK: p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with the t(11;14)(q13;q32). Blood 86:2892, 1995
65. Greiner TC, Moynihan MJ, Chan WC, Lytle DM, Pederson A, Anderson JR, Weisenburger DD: p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 1996 (in press)
66. Hirama T, Koeffler HP: Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841, 1995
67. Lane DP: p53, guardian of the genome. Nature 358:15, 1992
68. Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB: Overexpression of cyclin-D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8:3447, 1993
69. Hinds PW, Daudy SF, Eaton EN, Arnold A, Weinberg RA: Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91:709, 1994
70. Lovec H, Sewing A, Lucibello FC, Müller R, Möröy T: Oncogenic activity of cyclin D1 revealed through cooperation with Haras: link between cell cycle control and malignant transformation. Oncogene 9:323, 1994
71. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM: Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 13:2124, 1994
72. Lovec H, Grzeschiezek A, Kowalski MB, Möröy T: Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 13:3487, 1994
73. Lammie GA, Smith R, Silver J, Brookes S, Dickson C, Peters G: Proviral insertions near cyclin D1 in mouse lymphomas: A parallel for BCL1 translocations in human B-cell neoplasms. Oncogene 7:2381, 1992
74. Hanna Z, Jankowski M, Tremblay P, Jiang X, Milatovich A, Francke W, Jolicoeur P: The vin-1 gene, identified by proviral insertional mutagenesis, is the cyclin D2. Oncogene 8:1661, 1993
75. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669, 1994
76. Afar DEH, McLaughlin J, Sherr CJ, Witte ON, Roussel MF: Signaling by ABL oncogenes through cyclin D1. Proc Natl Acad Sci USA 92:9540, 1995
77. Weisenburger DD, Harrington DS, Armitage JO: B-cell neoplasia. A conceptual understanding based on the normal humoral immune response, in Rosen PP, Fechner RE (eds): Pathology Annual. East Norwalk, CT, Appleton and Lange, 1990, p 99
78. Bofill M, Janossy G, Janossa M, Buiford GD, Seymour GJ, Wernet P, Keleman E: Human B cell development: II. Subpopulations in the human fetus. J Immunol 134:1531, 1985
79. Antin JH, Emerson SG, Martin P, Gadol N, Ault KA: Leu1+(CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J Immunol 136:505, 1986
80. Asano S, Akaike Y, Muramatsu T, Mochizuki M, Tsuda T, Wakesa H: Immunohistologic detection of the primary follicle (PF) in human fetal and newborn lymph node anlages. Path Res Pract 189:921, 1993
81. Rabian-Herzog C, Lesage S, Gluckman E: Characterization of lymphocyte subpopulations in cord blood. Bone Marrow Transplant 9:64, 1992 (suppl 1)
82. Durandy A, Thuillier L, Forvielle M, Fischer A: Phenotypic and functional characteristics of human newborns' B lymphocytes. J Immunol 144:60, 1990
83. Hamburg A, Brynes RK, Reese C, Golomb HM: Human cord blood lymphocytes. Ultrastructural and immunologic surface marker characteristics; a comparison with B- and T-cell lymphomas. Lab Invest 34:207, 1976
84. Gobbi M, Caligaris-Cappio F, Janossy G: Normal equivalent cells of B cell malignancies: Analysis with monoclonal antibodies. Br J Haematol 54:393, 1983
85. Gadol N, Ault KA: Phenotypic and functional characterization of Leu-1 (CD5) B cells. Immunol Rev 93:23, 1986
86. Freedman AS, Boyd AW, Bieber FR, Daley J, Rosen K, Horowitz JC, Levy DN, Nadler LM: Normal cellular counterparts of B cell chronic lymphocytic leukemia. Blood 70:418, 1987
87. Abe M, Tominga K, Wakesa H: Phenotypic characterization of human B-lymphocyte subpopulations, particularly human CD5+ B-lymphocyte subpopulation within the mantle zones of secondary follicles. Leukemia 8:1039, 1994
88. Küppers R, Zhoa M, Hansmann ML, Rajewsky K: Tracing B cell development in human germinal centers by molecular analysis of single cells picked from histological sections. EMBO J 12:4955, 1993
89. H genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 84:403, 1994
90. Caligaris-Cappio F, Riva M, Tesio L, Schena M, Gaidano GL, Bergui L: Human normal CD5+ B lymphocytes can be induced to differentiate to CD5- B lymphocytes with germinal center features. Blood 73:1259, 1989
91. Holder MJ, Abbot SD, Milner AE, Gregory CD, Casamayor M, Johnson GD, MacClennan ICM, Gordon J: II-2 expands and maintains IgM plasmablasts from a CD5+ subset contained within the germinal centre cell-enriched (surface IgD-/CD39- buoyant) fraction of human tonsil. Int Immunol 5:1059, 1993
92. van den Oord JJ, de Wolf-Peeters C, Desmet VJ: The marginal zone in the human reactive lymph node. Am J Clin Pathol 86:475, 1986
93. van Krieken JHJM, von Schilling C, Kluin PM, Lennert K: Splenic marginal zone lymphocytes and related cells in the lymph node. A morphologic and immunohistochemical study. Hum Pathol 20:320, 1989
94. van den Oord JJ, de Wolf-Peeters C, Pulford KAP, Mason DY, Desmet VJ: Mantle-zone lymphoma. Immuno- and enzymehistochemical studies on the cell of origin. Am J Surg Pathol 10:780, 1986
95. Takeshita M, Masuda Y, Sumiyoshi Y, Ohshima K, Kikuchi M, Kimura N, Okamura T, Nishimura J, Kozura M: Clinicopathologic, enzyme and histochemical studies of centrocytic (mantle cell) lymphoma: Comparison with other types of low grade lymphoma based on the updated Kiel Classification. Acta Pathol Jpn 43:244, 1993
96. Harris NL, Bahn AK: Mantle-zone lymphoma. A pattern produced by lymphomas of more than one cell type. Am J Surg Pathol 9:872, 1985
97. Weisenburger DD, Linder J, Daley DT, Armitage JO: Intermediate lymphocytic lymphoma. An immunohistologic study with comparison to other lymphocytic lymphomas. Hum Pathol 18:781, 1987
98. Ellison DJ, Nathwani BN, Cho SY, Martin SE: Interfollicular small lymphocytic lymphomas. The diagnostic significance of pseudofollicles. Hum Pathol 20:1108, 1989
99. Perry DA, Bast MA, Armitage JO, Weisenburger DD: Diffuse intermediate lymphocytic lymphoma. A clinicopathologic study with comparison to small lymphocytic lymphoma and diffuse small cleaved cell lymphoma. Cancer 66:1995, 1990
100. Fraga M, Leoret E, Sanchez-Verde L, Orradre JL, Campo E, Bosch F, Piris MA: Mucosal mantle cell (centrocytic) lymphomas. Histopathology 26:413, 1995
101. Pileri S, Rivano MT, Gobbi M, Taruseio D, Lennert K: Neoplastic and reactive follicles within B-cell malignant lymphomas. A morphological and immurtological study of 30 cases. Hematol Oncol 3:243, 1985
102. Cheng AL, Su IJ, Tien HF, Wang CC, Chen YC, Wang CH: Characteristic clinicopathologic features of adult B-cell lymphoblastic lymphoma with special emphasis on differential diagnosis with an atypical form probably of blastic lymphocytic lymphoma of intermediate differentiation origin. Cancer 73:706, 1994
103. Brittinger G, Bartels H, Common H, Dühmke E, Fülle HH, Gunzer U, Gyenes T, Heinz R, König E, Meusers P, Paukstat M, Pralle H, Theml H, Kopeke W, Thieme C, Zwingers T, Musshoff K, Stacher A, Brücher H, Herrmann F, Ludwig WD, Pribilla W, Burger-Schüler A, Löhr GW, Gemmel H, Oertel J, Gerhartz H, Koeppen KM, Boll I, Huhn D, Binder T, Schoengen A, Nowicki L, Pees HW, Scheurlen PG, Leopold H, Wannenmacher M, Schmidt M, Löffler H, Michlmayr G, Thiel E, Zettel R, Rühl U, Wilke HJ, Schwarze EW, Stein H, Feller AC, Lennert K (Kiel Lymphoma Study Group): Clinical and prognostic relevance of the Kiel classification of non-Hodgkin's lymphomas. Results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol 1984; 2:269, 1984
104. Meusers P, Engelhard M, Bartels H, Binder T, Fülle HH, Görg K, Gunzer U, Havemann K, Kayser W, König E, König HJ, Kuse R, Löffler H, Ludwig WD, Mainzer K, Martin H, Pralle H, Schoppe WD, Staiger HJ, Theml H, Zurborn KH, Swingers TH, Lennert K, Brittinger G: Multicentre randomized therapeutic trial for advanced centrocytic lymphoma. Anthracycline does not improve prognosis. Hematol Oncol 7:365, 1989
105. Bookman MA, Lardelli P, Jaffe ES, Duffey PL, Longo DL: Lymphocytic lymphoma of intermediate differentiation: Morphologic, immunophenotypic, and prognostic factors. J Natl Cancer Inst 82:742, 1990
106. Berger F, Felman P, Sonet A, Salles G, Bastion Y, Bryon PA, Coiffier B: Nonfollicular small B-cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome. Blood 83:2829, 1994
107. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM: A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including mucosa-associated lymphoid tissue and monocytoid B cell categories): A Southwest Oncology Group study. Blood 85:1075, 1995
108. Zucca E, Roggero E, Pinotti G, Pedrinis E, Cappella C, Venco A, Cavalli F: Patterns of survival in mantle cell lymphoma. Ann Oncol 6:259, 1995
109. Teodorovic I, Pittaluga S, Kluin-Nelemans JC, Meerwaldt JH, Hagenbeek A, van Glabbeke M, Somers R, Bijnens L, Noordijk EM, De Wolf Peeters C: Efficacy of four different regimens in 64 mantle-cell lymphoma cases: Clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. J Clin Oncol 13:2819, 1995
110. Plank L, Lennert K: Centrocytic lymphoma. Am J Surg Pathol 17:638, 1993
111. Garcia-Conde J, Cabanillas F: Mantle cell lymphoma: A new lymphoproliferative entity with definite histopathological patterns, clinical characteristics and prognostic factors, and an investigational therapeutic approach. Ann Oncol 6:305, 1995
112. Stewart DA, Vose JM, Weisenburger DD, Anderson JR, Ruby EI, Bast MA, Bierman PJ, Kessinger A, Armitage JO: The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Ann Oncol 6:263, 1995
113. Coffier B, Hiddemann W, Stein H. Mantle cell lymphoma: A therapeutic dilemma. Ann Oncol 6:208, 1995
114. Ohno T, Oka K, Yamaguchi M, Kita K, Shirakawa S: Frequent expression of shared idiotypes in mantle cell lymphoma and extranodal small lymphocytic/non-mantle cell diffuse small cleaved lymphoma. Leukemia 9:1935, 1995
115. 131I] anti-Bl (anti-CD20) antibody. N Engl J Med 329:459, 1993
116. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266:1821, 1994
117. Peng B, Mehta NH, Fernandez H, Chan CC, Ravechi E: Growth inhibition of malignant CD5+ B(B1) cells by antisense IL-10 oligonucleotide. Leuk Res 19:159, 1995
118. Weisenburger DD: Mantle cell lymphoma, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams & Wilkins, 1992, p 617
119. Arnold A: The cyclin D1/PRAD1 oncogene in human neoplasia. J Invest Med 43:543, 1995